Product Information
RIVASTIGMINE 1.5 MG CAPSULE is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1542 per EA under NDC 33342008909. Its NADAC has been published 577 times since Jun 10, 2015.
Strength
1.5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342008909
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203148On Market Since
9/2/2014
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 1.5 MG CAPSULE has been published 577 times since Jun 10, 2015, and over the history we have for it it has declined 89.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1542 per EA |
|---|---|
| All-time high | $1.6507 (Jul 15, 2015) |
| All-time low | $0.1380 (Nov 22, 2023) |
| 52-week high | $0.1894 |
| 52-week low | $0.1458 |
| Median price | $0.3540 |
| Average price | $0.4865 |
| Largest weekly change | +49.6% (Oct 19, 2022) |
| Weeks tracked | 577 |
| Tracking since | Jun 10, 2015 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 1.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 1.5 MG CAPSULE, manufactured by Macleods Pharmaceuticals Limited, is $0.1542 per EA (NDC 33342008909), effective Jun 24, 2026.
How has the price of RIVASTIGMINE 1.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has declined 89.5%. It has been tracked across 577 weekly CMS publications since Jun 10, 2015.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 1.5 MG CAPSULE?
Since Jun 10, 2015, the NADAC for RIVASTIGMINE 1.5 MG CAPSULE has ranged from a low of $0.1380 (Nov 22, 2023) to a high of $1.6507 (Jul 15, 2015), with a median of $0.3540 per EA.
Are there cheaper alternatives to RIVASTIGMINE 1.5 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as RIVASTIGMINE 1.5 MG CAPSULE, but none are currently priced below it.
Who manufactures RIVASTIGMINE 1.5 MG CAPSULE?
RIVASTIGMINE 1.5 MG CAPSULE (NDC 33342008909) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification